Seeing Is Believing

Currently out of the existing stock ratings of Elmar Kraus, 14 are a HOLD (40%), 21 are a BUY (60%).
Analyst Elmar Kraus, currently employed at DZ BANK, carries an average stock price target met ratio of 87.5% that have a potential upside of 24.03% achieved within 370 days.
Elmar Kraus’s has documented 69 price targets and ratings displayed on 12 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on GILD, Gilead Sciences at 13-Feb-2025.
Analyst best performing recommendations are on AZN (ASTRAZENECA PLC ADR).
The best stock recommendation documented was for AZN (ASTRAZENECA PLC ADR) at 2/11/2022. The price target of $124.66 was fulfilled within 46 days with a profit of $21.5 (20.84%) receiving and performance score of 4.53.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Sell Since 17-Mar-2026
$175
$-52.6 (-23.11%)
$150
20 days ago
(10-Sep-2026)
0/3 (0%)
$-40.43 (-18.77%)
Buy Since 15-May-2026
$245
$17.4 (7.64%)
$225
27 days ago
(03-Sep-2026)
5/9 (55.56%)
$20.49 (9.13%)
69
Buy Since 04-Mar-2022
$260
$32.4 (14.24%)
$240
1 months 5 days ago
(25-Aug-2026)
57/87 (65.52%)
$39.23 (17.77%)
169
Buy Since 28-Sep-2022
$241
$13.4 (5.89%)
$221
1 months 26 days ago
(04-Aug-2026)
25/42 (59.52%)
$32.55 (15.62%)
152
Hold Since 06-Jan-2023
$215
$-12.6 (-5.54%)
$200
1 months 27 days ago
(03-Aug-2026)
29/38 (76.32%)
$13.18 (6.53%)
220
What Year was the first public recommendation made by Elmar Kraus?